$4.23+0.95%
2026-10-06 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Unicycive Therapeutics last closed at $4.23 (+0.95%) on 2026-10-06. Listed on Nasdaq. Trailing 12 months PER is -3.2×. Its overall grade ranks 513 of 740 stocks in Healthcare.
About this company
Unicycive Therapeutics last closed at $4.23 (+0.95%) on 2026-10-06. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall C+ · 513/740
Valuation grade B+
Related stocks
- Otsuka PharmaceuticalCustomer
Unicycive의 후속 상업화/라이선스 파트너로 거론되는 대형 제약사
- AstraZenecaCompetitor
투석·신장질환 영역에서 경쟁 가능한 대형 글로벌 제약사
- AmgenCompetitor
만성신장질환 및 관련 치료제 시장에서 경쟁 가능한 대형 바이오/제약사
About Unicycive Therapeutics
- What technical signals does Unicycive Therapeutics (UNCY) have?
- Unicycive Therapeutics current technical signals: no active technical signal.
- Is Unicycive Therapeutics a cup-and-handle pattern?
- No. Unicycive Therapeutics has no valid Cup signal right now.
- What published figures are available for Unicycive Therapeutics?
- Market cap: $90.91M. Trailing 12 months PER: -3.2×. Latest quarter PBR: 2.14×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Unicycive Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy